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Background and purpose   The impact of large, randomized trials 
in orthopedic surgery on surgeons’ preferences for a particular 
surgical  approach  remains  unclear.  We  surveyed  surgeons  to 
assess whether they would change practice based upon results of 
a large, multicenter randomized controlled hip fracture trial. 
Methods   We conducted a cross-sectional survey among Inter-
national  Hip  Fracture  Research  Collaborative  (IHFRC)  sur-
geons and surgeons who were members of Arbeitsgemeinschaft 
fuer Osteosynthesefragen - Association for the Study of Internal 
Fixation (AO/ASIF) to determine the likelihood that they would 
change practice based on findings of a proposed large, multicenter 
randomized controlled trial (the Hip Fracture Evaluation with 
Alternatives of Total Hip Arthroplasty versus Hemi-Arthroplasty 
(HEALTH) study). We asked surgeons their current preferences 
for  the  management  of  displaced  femoral  neck  fractures  and 
whether a trial that definitively revealed a substantial improve-
ment in function and quality of life with no difference in risk of 
revision surgery was important and would cause them to change 
practice. 
Results   Of 883 surgeons surveyed, 210 responded from IHFRC 
and 586 from AO/ASIF (a response rate of 90%). Most surgeons 
(61%)  preferred  hemiarthroplasty  (HA)  for  treating  displaced 
femoral  neck  fractures.  72%  of  responding  surgeons  believed 
that a substantial improvement in patient function with total hip 
arthroplasty (THA) and no adverse effects on revision surgery 
would be an important finding. Moreover, of 483 surgeons who 
preferred  hemiarthroplasty,  62%  would  change  their  practice 
based upon the findings of the trial. 
Interpretation   Large clinical trials in orthopedics are worth-
while endeavors, as they have the potential to change practice 
among surgeons. Surgeons seem willing to adopt alternative sur-
gical approaches if the evidence is compelling and sound. 

Evidence-based medicine (EBM) is “the process of systemati-
cally finding, appraising, and using contemporaneous research 
findings as the basis for clinical decisions” (Rosenberg and 
Donald 1995). According to this principle, clinical decisions 
should mainly be guided by the results of the best available 
evidence. At the top of the hierarchy of evidence is the ran-
domized controlled trial (Brighton et al. 2003). 
Despite the increased enthusiasm for EBM, it is question-
able whether surgeons’ preferences for a particular surgical 
approach can be influenced by high-quality evidence. A French 
survey showed that although 75% of surgeons said they used 
results  from  randomized  controlled  trials,  only  25%  could 
provide the results of a randomized controlled trial that had 
actually changed their practice (Millat et al. 1999). In addi-
tion, for 58% of English hospital physicians, evidence from 
EBM sources contributed to changes in their clinical practice 
(Coleman and Nicholl 2001). 
The extent to which a surgeon puts EBM into practice could 
be lower for surgeons who are not very research-conscious or 
interested in research (Kizer et al. 1999), or for surgeons who 
do not have enough knowledge about or experience of EBM 
(McAlister et al. 1999). Secondly, the perceived importance of 
outcomes might influence the implementation of the results. 
Given that conduction of large, randomized trials in orthope-
dic surgery requires a large investment of funding, one could 
argue that only studies that have the potential to change surgi-
cal practice should receive funding priority. 
Conflicting evidence (Blomfeldt et al. 2007, Goh et al. 2008, 
Macaulay et al. 2008) and expert opinion (Bhandari et al. 2005) 
about  the  optimal  treatment  of  displaced  (Garden  III–IV) 
(Garden 1961) femoral neck fractures have led to conduction 
of a pilot multinational randomized trial entitled “Hip Fracture 
Evaluation with Alternatives of Total Hip Arthroplasty versus 
Hemi-Arthroplasty” (HEALTH). This trial is evaluating the 
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comparing THA and HA regarding revision surgery, function, 
and quality of life in 2,500 otherwise healthy elderly patients 
with displaced femoral neck fractures. 
The purpose of the present survey was to assess whether 
orthopedic surgeons would change practice based on a large, 
multicenter randomized controlled trial if it revealed a sig-
nificant improvement in patient-important outcomes. We also 
tried to explore the difference between surgeons with an inter-
est in research and those without any research interest. 
Methods
This survey of surgeons was based on an ongoing randomized 
trial evaluating alternative arthroplasty approaches in patients 
with displaced femoral neck fractures. 
The HEALTH randomized trial
The HEALTH randomized controlled trial asks the primary 
question:  In  patients  over  50  years  who  have  sustained  a 
displaced femoral neck fracture, what is the rate of revision 
surgery at 2 years in those treated with THA as opposed to 
HA? Study personnel monitor critical aspects of periopera-
tive care and rehabilitation for protocol deviations. In the pilot 
study, the investigators are evaluating a novel expertise-based 
design,  screening  procedures,  consent  rates,  adherence  to 
study protocols, and follow-up rates with a view to streamlin-
ing these procedures. The primary outcome is revision surgery 
within 2 years of surgery. The secondary outcomes include 
patient  function  (Western  Ontario  McMaster  osteoarthritis 
index (WOMAC), timed up-and-go test (TUG)), quality of 
life (SF-12 version 2), and health utility (EuroQol-5D (EQ-
5D)).  Investigators  will  independently  adjudicate  revision 
surgery rates at regular intervals up to 2 years. Funding has 
been received from the Canadian Institutes of Health Research 
(CIHR) and the National Institute of Arthritis, Musculoskel-
etal, and Skin Diseases (NIAMS) within the National Insti-
tutes of Health (NIH) to begin a pilot study at 17 centers in the 
United States, Canada, Europe, and Australia. The HEALTH 
pilot study will include 156 pilot patients to provide infor-
mation on the feasibility of a larger, definitive trial involving 
2,500 patients. In addition, funding has been received from the 
ZonMw, the Netherlands Organization for Health Research 
and Development, for 7 centers and 150 patients in the Neth-
erlands. HEALTH began recruitment in December 2008 and 
as of early September 2009, 40 patients have been enrolled 
across 13 centers screening for patients. The hypothesis is that 
total hip arthroplasty will have similar or lower rates of revi-
sion surgery (i.e. within 5% of each other) and higher func-
tional outcome scores (i.e. 6 point difference in SF-12 version 
2) at 2 years compared to hemiarthroplasty. 
Survey design 
We conducted a cross-sectional survey among International 
Hip Fracture Research Collaborative (IHFRC) surgeons (www.
ifrca.ca) and AO/ASIF membership surgeons to determine the 
likelihood that they would change practice based on the find-
ings of our proposed large, multicenter randomized controlled 
trial (the HEALTH study). The IHFRC is a collaboration of 
surgeons who are interested in participating in large trials on 
the optimal treatment of hip fracture.
The survey involved 3 key areas. First, the participants were 
asked about their current preferences for the management of 
displaced femoral neck fractures in otherwise healthy elderly 
patients (THA, HA, or internal fixation). Next, the surgeons 
were asked whether they (1) would find it important and (2) 
would  change  their  surgical  practice  if  the  HEALTH  trial 
revealed that THA was superior regarding pain, function, and 
quality of life (QoL)), with no difference in risk of revision 
surgery. The response options for the latter 2 questions were 
presented as Likert scales. Superiority was defined as signifi-
cantly reduced pain score with total hip arthroplasty (p < 0.05) 
and significantly improved functional score (SF-12 version 2, 
6 points). We defined lack of inferiority of total hip replace-
ment as being within 5% of the revision surgery rate of hemi-
arthroplasty at 2 years. 
Survey administration 
We identified all active orthopedic surgeons who were mem-
bers of the IHFRC and all surgeons with AO/ASIF member-
ship. The survey was sent to each participant by both e-mail 
and fax, and was accompanied by a personalized cover letter 
explaining the purpose of the survey. At 2, 4, 8, and 12 weeks 
after  the  initial  mailing,  we  re-sent  the  survey  to  all  non-
responders. Individual responses remained confidential, and 
completion of the questionnaire was voluntary. 
Data analysis
We summarized frequencies of the responses as percentages. 
All  answers  were  included  in  the  analyses,  irrespective  of 
whether the entire questionnaire was completed or not. For 
comparative  analysis  between AO/ASIF  and  IHFRC  mem-
bers, the chi-square test was used. Results with a p-value of 
< 0.05 were considered significant.
Results 
Of the 883 surgeons surveyed, 210 from IHFRC responded 
and 586 from AO/ASIF responded (giving a response rate 
of 90%) (Table 1). Most surgeons (n = 483, 61%) preferred 
hemiarthroplasty for treating displaced femoral neck fractures 
(Table 2). Notably, more IHFRC members preferred HA than 
AO/ASIF members (74% vs. 56%, p < 0.001).
72% of the surgeons who responded believed that a sub-
stantial improvement in patient function and less pain with 
THA, with similar revision surgery rates to HA, would be an 
important finding (definitely important: 32%; possibly impor-124  Acta Orthopaedica 2010; 81 (1): 122–125
tant: 40%) (Table 3). A higher proportion of IHFRC members 
considered such findings to be definitely important compared 
to AO/ASIF members (67% vs. 20%, p < 0.001). 
Of 483 surgeons who preferred HA for the management of 
displaced femoral neck fractures in the elderly, 62% responded 
that they would change their practice based upon the findings 
of a trial reporting superiority of THA (Table 4). Of those, 
13% would definitely, 26% would very likely, and 24% would 
be somewhat likely to change their practice from HA to THA 
(Table  4).  Surgeons  who  were  members  of AO/ASIF  and 
preferred HA were less likely to change their practice than 
surgeons who were members of the IHFRC (48% vs. 92%, 
p < 0.001). 
Discussion
Our  findings  support  the  notion  that  surgeons  will  change 
practice  if  large,  high-quality  trials  suggest  that  there  are 
important benefits with alternative therapies. Most surgeons 
in our survey preferred HA for the management of displaced 
femoral neck fractures. If our findings are correct (i.e. that 
62% would switch to THA if a trial confirmed its superiority), 
the proportion of surgeons using THA as the preferred treat-
ment would increase from 15% (116) to 52% (416). The most 
conservative estimate of impact of the HEALTH trial, if posi-
tive, would increase the proportion of surgeons using THA 
from 15% (116) to 38% (302). 
Whether or not funding of major research by the public or 
private sector would require assurance of such willingness to 
change practice remains unknown. Our findings certainly sug-
gest that the results of large trials can have an impact on clini-
cal practice. This emphasizes the widespread need for ortho-
pedic surgeons to support and participate in such trials. 
This survey had several limitations. First, only the scenario 
of superiority of THA over HA with respect to patient func-
tion was presented to participants of the survey. Our findings 
are  not  generalizable  to  any  other  possible  study  findings. 
Secondly, it may not be possible to generalize the results of 
this survey to more complicated cases, as the scenario in the 
survey assumed that patients were otherwise healthy. In addi-
Table  1.  Geographical  location  of  the 
respondents (n = 796)
Continent of practice   Number (%) of 
  respondents
Europe  361 (45)
North America  161 (20)
Asia  132 (17)
South America    41 (5.2)
Africa    11 (1.4)
Not answered     90 (11)
Table 2. Management preferences of the respondents (n = 796)
  Number (%) of respondents
   IHFRC  AO/ASIF  Total 
Intervention  (n = 210)   (n = 586)  (n = 796) 
Hemiarthroplasty   155 (74)   328 (56)   483 (60)
Total hip arthroplasty     20 (9.5)     96 (16)   116 (15)
Internal fixation     10 (4.8)   129 (22)   139 (18)
No single preference     19 (9.1)       0 (0.0)     19 (2.3)
Not answered       6 (2.9)     33 (5.6) a     39 (4.9)
a p < 0.001 for differences between proportions across IHFRC and 
AO/ASIF members.
Table  4.  Likelihood  that  surgeons  using  HA  would  change  their 
practice on the basis of patient-important findings a that would sup-
port total hip arthroplasty
  Number (%) of respondents
Likelihood of    IHFRC  AO international  Total
changing  (n = 155)   (n = 328)  (n = 483)
Definitely     49 (32)    13 (4.0)    62 (13)
Very likely    65 (42)    59 (18)  124 (26)
Somewhat likely    28 (18)    86 (26)  114 (24)
Total (change)   142 (92)   158 (48)   300 (62)
Not likely      7 (4.5)    87 (27)    94 (20)
Never      0 (0.0)      5 (1.5)      5 (1.0)
Total (no change)       7 (4.5)    92 (28)    99 (21)
Uncertain      5 (3.2)    56 (17)    61 (13)
Not applicable      0 (0.0)      1 (0.3)      1 (0.2)
Not answered       1 (0.6)     21 (6.4) b     22 (4.6)
a In terms of reduced pain and improved patient function and quality 
  of life.
 b p < 0.001 for differences between proportions across IHFRC and 
  AO/ASIF members.
Table 3. Perceived importance to orthopedic practice of patient-
important findings a that would support total hip arthroplasty 
  Number (%) of respondents
  IHFRC  AO/ASIF  Total
Perceived importance  (n = 210)  (n = 586)  (n = 796)
Definitely important  141 (67)  116 (20)  257 (32)
Possibly important    55 (26)  261 (45)  316 (40)
Total (important)  196 (93)  377 (64)  573 (72)
Possibly unimportant      4 (1.9)    43 (7.3)    47 (5.9)
Definitely unimportant      2 (1.0)    19 (3.2)    21 (2.6)
Total (unimportant)      6 (2.9)    62 (11)    68 (8.5)
Unsure      3 (1.4)    89 (15)    92 (12)
Not applicable      0 (0.0)      2 (0.3)      2 (0.3)
Not answered      5 (2.4)    56 (9.6) b    61 (7.7)
a In terms of reduced pain and improved patient function and quality 
  of life.
b p < 0.001 for differences between proportions across IHFRC and 
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tion, the participants of this survey might not represent ortho-
pedic  surgeons  in  general,  since  all  participating  surgeons 
were members of an organization of orthopedic surgery and 
one could question whether non-members might respond as 
often to surveys as members. Furthermore, hip fractures in the 
elderly are associated with a relatively high degree of reduc-
tion of function compared to other fractures, which makes it 
less useful to apply these results to trials comparing treatments 
of other fractures. However, patient-important outcomes are 
likely to influence all clinical decisions of surgeons and physi-
cians, independently of the treatments compared. 
Despite these limitations, our study was strengthened by 
the high response rate of 90%, which reduces potential non-
responder bias. Also, since a sample of average members (AO/
ASIF) and a sample of members who are highly research-ori-
entated (IHFRC) were included, the participants of this survey 
probably represent a cross-section of the overall orthopedic 
surgery community. 
The concept of EBM was first described in the literature in 
1991 (Guyatt 1991). Using best evidence, one could expect that 
surgical decisions would be based on results from large, mul-
ticenter randomized controlled trials. Unfortunately, results 
from randomized controlled trials do not contribute very often 
to the clinical decision making of both general surgeons and 
hospital physicians (Millat et al. 1999, Coleman and Nicholl 
2001, Hadley et al 2007). Our findings do, however, suggest 
that orthopedic surgeons may in fact be influenced by high-
quality data. 
Cardiologists have been shown to be more likely to increase 
their prescription of drugs that have been demonstrated to be 
effective  in  recent  randomized  controlled  trials  when  they 
have participated in trials themselves (Kizer et al. 1999). As 
the IHFRC members are specifically interested in trials on the 
optimal treatment of hip fractures, they are more likely than 
AO/ASIF members to indicate that they would change their 
practice based on the HEALTH trial. Also, one could reason 
that IHFRC members would consider superiority of THA over 
HA to be more important than AO/ASIF members, since HA is 
more frequently used by IHFRC members (74%) than by AO/
ASIF members (56%). Our results show that a substantially 
higher  proportion  of  IHFRC  members  would  change  their 
clinical practice. Furthermore, a higher proportion of IHFRC 
members would consider the findings to be definitely impor-
tant as compared to AO/ASIF members. Thus, our results sup-
port the hypothesis that research-orientated surgeons would be 
more likely to change their practice based upon the findings of 
a large, randomized controlled trial. 
The survey was planned and designed by JP, SS, and MB. It was conducted by 
JP, SS, BPH, and MB. The statistical analysis was performed by BGD, BWK, 
and JP. BGD, BWK, JP, SS, and MB participated in the interpretation of the 
results and in preparation of the manuscript. 
We thank Helena Viveiros and Eric Morrison for their assistance with admin-
istration of the survey. No funding was received for the preparation of this 
manuscript. Mohi Bhandari is funded, in part, by a Canada Research Chair. 
The survey was based on an ongoing randomized trial funded by The Cana-
dian Institutes of Health Research (CIHR), the National Institute of Arthritis, 
Musculoskeletal, and Skin Diseases (NIAMS) at the National Institutes of 
Health (NIH), USA, and ZonMw, the Netherlands Organization for Health 
Research and Development.
Bhandari M, Devereaux P J, Tornetta P, III, Swiontkowski M F, Berry D J, 
Haidukewych G, Schemitsch E H, Hanson B P, Koval K, Dirschl D, Leece 
P, Keel M, Petrisor B, Heetveld M, Guyatt G H and the The International 
Hip Fracture Research Collaborative. Operative management of displaced 
femoral neck fractures in elderly patients. An international survey. J Bone 
Joint Surg (Am) 2005; 87: 2122-30.
Blomfeldt R, Törnkvist H, Eriksson K, Söderqvist A, Ponzer S, Tidermark 
J. A randomised controlled trial comparing bipolar hemiarthroplasty with 
total hip replacement for displaced intracapsular fractures of the femoral 
neck in elderly patients. J Bone Joint Surg (Br) 2007; 89: 160-5.
Brighton B, Bhandari M, Tornetta P, III, Felson D T. Part I. Methodologic 
issues in the design of orthopedic studies. Clin Orthop 2003; (413): 19-24.
Coleman P, Nicholl J. Influence of evidence-based guidance on health policy 
and clinical practice in England. Qual Health Care 2001; 10: 229-37.
Garden R S. Low-angle fixation in fractures of the femoral neck. J Bone Joint 
Surg (Br) 1961; 43: 647-64.
Guyatt G H. Evidence-based medicine. ACP J Club 1991; 114: A16.
Goh S K, Samuel M, Su D H, Chan E S, Yeo S J. Meta-analysis compar-
ing total hip arthroplasty with hemiarthroplasty in the treatment of dis-
placed neck of femur fracture. J Arthroplasty 2008: Aug 11 [Epub ahead 
of print].
Hadley J A, Wall D, Khan K S. Learning needs analysis to guide teaching 
evidence-based medicine: knowledge and beliefs amongst trainees from 
various specialities. BMC Med Educ 2007; 10: 11-6.
Kizer J R, Cannon C P, McCabe C H, Mueller H S, Schweiger M J, Davis V 
G, Perritt R, Antman E M. Trends in the use of pharmacotherapies for acute 
myocardial infarction among physicians who design and/or implement ran-
domized trials versus physicians in routine clinical practice: the MILIS-
TIMI experience. Multicenter Investigation on Limitation of Infarct Size. 
Thrombolysis in Myocardial Infarction. Am Heart J 1999; 137: 79-92.
Macaulay W, Nellans K W, Garvin K L, Iorio R, Healy W L, Rosenwasser M 
P; other members of the DFACTO Consortium. Prospective randomized 
clinical trial comparing hemiarthroplasty to total hip arthroplasty in the 
treatment of displaced femoral neck fractures: winner of the Dorr Award. J 
Arthroplasty 2008; 23: 2-8.
McAlister F A, Graham I, Karr G W, Laupacis A. Evidence-based medicine 
and the practicing clinician.” J Gen Intern Med 1999; 14: 236-42.
Millat B, Fingerhut A, Flamant Y, Hay J M, Fagniez P L, Farah A, Duron 
J J, Courchevel J M. Survey of the impact of randomised clinical trials 
on surgical practice in France. French Associations for Research in Sur-
gery (AURC and ACAPEM). Association Universitaire de Recherche en 
Chirurgie.  Association  des  Chirurgiens  de  l’Assistance  Publique  pour 
l’Evaluation Médicale. Eur J Surg 1999; 165: 87-94.
Rosenberg W, Donald A. Evidence based medicine: an approach to clinical 
problem-solving. BMJ 1995 310: 1122-6.